Home/R3 Vascular/Kamal Ramzipoor
KR

Kamal Ramzipoor

CTO & Founder

R3 Vascular

R3 Vascular Pipeline

DrugIndicationPhase
MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold SystemPeripheral Arterial Disease (PAD) - lesions in superficial femoral and proximal popliteal arteriesUnknown